nuclear receptor subfamily 3 group C member 2
Última atualização 18 Abr 2023
Atende aos diretrizes editoriais
- BaixarBaixar
- Compartilhar
- Language
- Discussão
- Ask Patient
- Versão em Áudio
- Adicionar às fontes preferidas no Google
A NR3C2 gene provides instructions for making a protein called the mineralocorticoid receptor. This protein is important in regulating the amount of sodium in the body. Sodium regulation plays a role in blood pressure control and fluid balance. Certain hormones called mineralocorticoids attach (bind) to and turn on (activate) the mineralocorticoid receptor. Aldosterone is one mineralocorticoid that activates the mineralocorticoid receptor. The activated mineralocorticoid receptor acts as a transcription factor, which is a protein that binds to specific regions of DNA and helps control the activity (transcription) of particular genes.
Escolhas de vídeos para GenesBiblioteca de vídeos
Normal function
A NR3C2 gene provides instructions for making a protein called the mineralocorticoid receptor. This protein is important in regulating the amount of sodium in the body. Sodium regulation plays a role in blood pressure control and fluid balance. Certain hormones called mineralocorticoids attach (bind) to and turn on (activate) the mineralocorticoid receptor. Aldosterone is one mineralocorticoid that activates the mineralocorticoid receptor. The activated mineralocorticoid receptor acts as a transcription factor, which is a protein that binds to specific regions of DNA and helps control the activity (transcription) of particular genes.
The mineralocorticoid receptor regulates specialized proteins in the cell membrane that control the transport of sodium or potassium into cells. In response to signals that sodium levels in the body are low, the mineralocorticoid receptor increases the number and activity of these proteins at the cell membrane, especially in certain kidney cells. One of these proteins transports sodium into the cell, while another protein simultaneously transports sodium out of the cell and potassium into the cell. These proteins help keep sodium in the body through a process called reabsorption and remove potassium from the body through a process called secretion.
Conditions referring to this gene or chromosome
Other names
aldosterone receptor
FLJ41052
MCR
MCR_HUMAN
MGC133092
mineralocorticoid receptor
mineralocorticoid receptor 1
mineralocorticoid receptor delta
MLR
MR
NR3C2VIT
nuclear receptor subfamily 3, group C, member 2
Related patient information and medicines

Patient information leaflet
Neuroblastoma
Neuroblastoma is a cancer affecting developing nerve cells. Neuroblastoma is a rare cancer and most often occurs in children under 5 years old. Neuroblastoma often starts in the tummy (abdomen) but can spread to other parts of the body, especially bones, liver and skin. The treatments for neuroblastoma include surgery, chemotherapy and.

Patient information leaflet
Câncer de mama
Breast cancer is the most common cancer in women. Most cases occur in women over the age of 50 but breast cancer can occur in younger women. Over 3 out of 4 women diagnosed with breast cancer are still a... What is breast cancer. What is breast cancer? | Patient Explainers Breast cancer is the most common cancer in women. Most cases occur in women.

Patient information leaflet
Tumor de Wilms
A Wilms' tumour is a type of kidney cancer. Wilms' tumours can appear in older children and adults but this is very rare. A Wilms' tumour is also known as a nephroblastoma Wilm's tumour is the most common type of kidney cancer in children but is very rare. About 80 children are diagnosed with a Wilms' tumour each year in the UK. The most common.

Patient information leaflet
Imunização contra a gripe
All viruses have evolved to try and increase their own numbers constantly by infe... Expert scientists and the World Health Organization (WHO) monitor flu viruses throughout the world and predict which gripe strains they think are going to be the most active each year and therefore which strains are to be included in the current year's vaccine. This.

Patient information leaflet
Genes BRCA
There are a few known gene alterações (mutations) that can increase the risk of certain cancers, and tests available for some of them, including BRCA1. The BRCA1 and BRCA2 genes normally protect against certain cancers, particularly breast cancer and ovarian cancer. If there is a mutation in one of these genes then this may mean that the protection.

Patient information leaflet
Distonia
A dystonia is a lasting or frequently recurring and unwanted (involuntary) muscle contraction. It can affect one or more muscles in the body. There is no cure; however, there are different types of treatment which can help. These vary with the type of dystonia that you have. What is dystonia. A dystonia is lasting unwanted (involuntary) muscle.
Leitura adicional e referências
- nuclear receptor subfamily 3 group C member 2; MedlinePlus, National Library of Medicine.
- Chen SY, Bhargava A, Mastroberardino L, Meijer OC, Wang J, Buse P, Firestone GL, Verrey F, Pearce D. Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2514-9. doi: 10.1073/pnas.96.5.2514.
- Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, Meinke G, Tsai FT, Sigler PB, Lifton RP. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science. 2000 Jul 7;289(5476):119-23. doi: 10.1126/science.289.5476.119.
- Kolla V, Litwack G. Transcriptional regulation of the human Na/K ATPase via the human mineralocorticoid receptor. Mol Cell Biochem. 2000 Jan;204(1-2):35-40. doi: 10.1023/a:1007009700377.
- Martinez F, Mansego ML, Escudero JC, Redon J, Chaves FJ. Association of a mineralocorticoid receptor gene polymorphism with hypertension in a Spanish population. Am J Hypertens. 2009 Jun;22(6):649-55. doi: 10.1038/ajh.2009.39. Epub 2009 Mar 26.
- Pujo L, Fagart J, Gary F, Papadimitriou DT, Claes A, Jeunemaitre X, Zennaro MC. Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism. Hum Mutat. 2007 Jan;28(1):33-40. doi: 10.1002/humu.20371.
- Rafestin-Oblin ME, Souque A, Bocchi B, Pinon G, Fagart J, Vandewalle A. The severe form of hypertension caused by the activating S810L mutation in the mineralocorticoid receptor is cortisone related. Endocrinology. 2003 Feb;144(2):528-33. doi: 10.1210/en.2002-220708.
- Riepe FG, Finkeldei J, de Sanctis L, Einaudi S, Testa A, Karges B, Peter M, Viemann M, Grotzinger J, Sippell WG, Fejes-Toth G, Krone N. Elucidating the underlying molecular pathogenesis of NR3C2 mutants causing autosomal dominant pseudohypoaldosteronism type 1. J Clin Endocrinol Metab. 2006 Nov;91(11):4552-61. doi: 10.1210/jc.2006-1161. Epub 2006 Sep 5.
- van Leeuwen N, Caprio M, Blaya C, Fumeron F, Sartorato P, Ronconi V, Giacchetti G, Mantero F, Fernandes-Rosa FL, Simian C, Peyrard S, Zitman FG, Penninx BW, de Kloet ER, Azizi M, Jeunemaitre X, Derijk RH, Zennaro MC. The functional c.-2G>C variant of the mineralocorticoid receptor modulates blood pressure, renin, and aldosterone levels. Hypertension. 2010 Nov;56(5):995-1002. doi: 10.1161/HYPERTENSIONAHA.110.155630. Epub 2010 Sep 20.
- Viengchareun S, Le Menuet D, Martinerie L, Munier M, Pascual-Le Tallec L, Lombes M. The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology. Nucl Recept Signal. 2007 Nov 30;5:e012. doi: 10.1621/nrs.05012.
Compartilhe seus pensamentos ou experiências com outros em nosso comunidades de pacientes.
Inscreva-se no boletim informativo do Patient
Sua dose semanal de conselhos de saúde claros e confiáveis - escritos para ajudá-lo a se sentir informado, confiante e no controle.
Ao se inscrever, você aceita nossos Política de Privacidade. Você pode cancelar a inscrição a qualquer momento. Nunca vendemos seus dados.

